首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   410篇
  免费   18篇
耳鼻咽喉   3篇
儿科学   12篇
妇产科学   3篇
基础医学   31篇
口腔科学   5篇
临床医学   21篇
内科学   120篇
神经病学   58篇
特种医学   7篇
外科学   37篇
综合类   2篇
预防医学   24篇
眼科学   1篇
药学   34篇
中国医学   1篇
肿瘤学   69篇
  2023年   2篇
  2022年   3篇
  2021年   4篇
  2020年   4篇
  2019年   4篇
  2018年   8篇
  2017年   5篇
  2016年   6篇
  2015年   12篇
  2014年   12篇
  2013年   30篇
  2012年   14篇
  2011年   18篇
  2010年   11篇
  2009年   14篇
  2008年   25篇
  2007年   32篇
  2006年   31篇
  2005年   19篇
  2004年   28篇
  2003年   17篇
  2002年   11篇
  2001年   7篇
  2000年   7篇
  1999年   9篇
  1998年   6篇
  1997年   3篇
  1996年   4篇
  1995年   2篇
  1994年   6篇
  1993年   2篇
  1992年   6篇
  1991年   4篇
  1990年   5篇
  1989年   6篇
  1988年   2篇
  1987年   6篇
  1985年   5篇
  1984年   8篇
  1983年   2篇
  1982年   7篇
  1981年   2篇
  1976年   4篇
  1973年   1篇
  1972年   1篇
  1970年   1篇
  1967年   1篇
  1966年   5篇
  1962年   1篇
  1960年   1篇
排序方式: 共有428条查询结果,搜索用时 15 毫秒
71.
72.
73.
The influence of sex on recovery from aphasia was investigated for oral expression and auditory verbal comprehension separately in 264 males and 121 females subdivided according to presence/absence of rehabilitation. The conclusions were that females recover significantly better than males in oral expression, but not in auditory verbal comprehension.These results are discussed with regard to the possible existence of a different cerebral organization in males and females.  相似文献   
74.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) was given by gavage to pregnant rats on the 1st–3rd days of gestation in dosages of 0 (control), 0.125, 0.5, and 2 μg/kg/day. The treatment did not increase pre- and postimplantation losses. Mean fetal weight was reduced at the 0.5 and 2 μg/kg dose levels.  相似文献   
75.
76.
77.
The presence of IgM paraproteinemia in low-grade lymphomas is usually considered a clinical syndrome known as Waldenstrom's macroglobulinemia (WM). In the WHO classification, WM is associated to lymphoplasmacytic lymphoma (LPL); it is a clinicopathologic entity characterized by a monoclonal expansion of predominantly small B-lymphocytes with variable plasmacytoid differentiation. LPL constitutes less than 5% of all NHL and it is associated with hepatitis C virus infection in 26% of cases. Cells of LPL/WM are B cells positive for monocytic Ig light chains, IgM, pan-B-cell markers, and negative for CD3 and CD103. The t(9;14)(p13;q32) is present in 50% of LPL, and determines PAX-5 over-expression. 6q21 deletion is observed in 42% of cases. LPL occurs in older adults. Clinical presentation usually consists of disseminated disease, but extranodal involvement and leukemic phase are rare. Most WM patients have symptoms attributable to tumour infiltration and/or monoclonal protein. In fact, a monoclonal serum paraprotein of IgM type and hyperviscosity symptoms may occur in more than 20% of cases (WM). Hyperviscosity syndrome is usually manifested by bleeding, blurring or loss of vision, dizziness, headache, and neurologic symptoms. Malignant infiltration of the CNS (Bing-Neel syndrome) is uncommon. LPL/WM is an indolent malignancy that is not usually curable with conventional treatments. The median survival of patients with LPL or WM is 50-60 months, transformation to large cell lymphoma may occur. Stage definition is irrelevant in WM considering that initiation of therapy is decided on the bases of prognostic factors and the development of disease-related symptoms and signs. The main adverse prognostic factors are older age, B symptoms, anemia, low albumin serum levels, raised SGOT, and high beta 2-microglobulin values. Several therapeutic alternatives for newly diagnosed or relapsed LPL/WM are available; however, the best location for every strategy is a matter of investigation. Several new drugs are being assessed in prospective trials. As a significant progress in this field, response criteria and therapeutic recommendations were updated during the Third International Workshop on WM (7-10 October 2004, Paris, France).  相似文献   
78.
79.
80.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issued in 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmunotherapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was also recommended in responding patients. In patients relapsing after an interval longer than 12 months from frontline therapy, we recommended chemoimmunotherapy with non cross‐resistant regimens followed by rituximab maintenance. High dose chemotherapy followed by hematopoietic stem cell transplant was recommended for young fit patients who achieve a response after salvage chemoimmunotherapy. Am. J. Hematol. 88:185–192, 2013. © 2012 Wiley Periodicals, Inc.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号